Livongo's flurry of recent activity is representative of a maturing digital therapeutics market — and its recent tie-ups reveal an approach digital therapeutics firms can take to wrangle in business.
And we've seen other players in the sector zeroing in on selling to insurers as a surefire way to capture a larger chunk of the market and rake in more cash: Diabetes management company DarioHealth that honing its budget in on its enterprise-facing channel — over its direct-to-consumer model — will drive revenue growth.$9 billion
by 2025, and we think that growth will largely be driven by increased payer appetite for products that improve health outcomes and reduce costs. So, it's likely that companies in the space will continue to focus more heavily on big-scale payer partnerships like this., Business Insider Intelligence's expert product suite keeping you up-to-date on the people, technologies, trends, and companies shaping the future of healthcare, delivered to your inbox 6x a week.
ประเทศไทย ข่าวล่าสุด, ประเทศไทย หัวข้อข่าว
Similar News:คุณยังสามารถอ่านข่าวที่คล้ายกันนี้ซึ่งเรารวบรวมจากแหล่งข่าวอื่น ๆ ได้
แหล่ง: BusinessInsider - 🏆 729. / 51 อ่านเพิ่มเติม »